Abbott Laboratories's Revenue by Segment
In fiscal year 2025, Abbott Laboratories's revenue by segment (products & services) are as follows:
- Diagnostic Products: $8.94 B
- Established Pharmaceutical Products: $5.54 B
- Medical Devices: $21.39 B
- Nutritional Products: $8.45 B
Learn more about Abbott Laboratories’s Revenue by Geography
Check out competitors to Abbott Laboratories in a side-by-side comparison.
Explore additional financial metrics for Abbott Laboratories.
Abbott Laboratories's Revenue Share by Segment
| Diagnostic Products | 9988000000 |
|---|---|
| Established Pharmaceutical Products | 5066000000 |
| Medical Devices | 16887000000 |
| Nutritional Products | 8154000000 |
| Diagnostic Products | 9341000000 |
|---|---|
| Established Pharmaceutical Products | 5194000000 |
| Medical Devices | 18986000000 |
| Nutritional Products | 8413000000 |
| Diagnostic Products | 8937000000 |
|---|---|
| Established Pharmaceutical Products | 5536000000 |
| Medical Devices | 21387000000 |
| Nutritional Products | 8451000000 |
The above chart shows Abbott Laboratories's revenue percentage share by segment (products and services).
In fiscal year 2023, Abbott Laboratories's revenue by segment is as follows:
- Diagnostic Products generated $9.99 B in revenue, representing 24.91% of its total revenue.
- Established Pharmaceutical Products generated $5.07 B in revenue, representing 12.63% of its total revenue.
- Medical Devices generated $16.89 B in revenue, representing 42.12% of its total revenue.
- Nutritional Products generated $8.15 B in revenue, representing 20.34% of its total revenue.
The biggest segment for Abbott Laboratories is the Medical Devices, which represents 42.12% of its total revenue.
The smallest segment for Abbott Laboratories is the Established Pharmaceutical Products, which represents 12.63% of its total revenue.
The above chart shows Abbott Laboratories's revenue percentage share by segment (products and services).
In fiscal year 2024, Abbott Laboratories's revenue by segment is as follows:
- Diagnostic Products generated $9.34 B in revenue, representing 22.28% of its total revenue.
- Established Pharmaceutical Products generated $5.19 B in revenue, representing 12.39% of its total revenue.
- Medical Devices generated $18.99 B in revenue, representing 45.28% of its total revenue.
- Nutritional Products generated $8.41 B in revenue, representing 20.06% of its total revenue.
The biggest segment for Abbott Laboratories is the Medical Devices, which represents 45.28% of its total revenue.
The smallest segment for Abbott Laboratories is the Established Pharmaceutical Products, which represents 12.39% of its total revenue.
The above chart shows Abbott Laboratories's revenue percentage share by segment (products and services).
In fiscal year 2025, Abbott Laboratories's revenue by segment is as follows:
- Diagnostic Products generated $8.94 B in revenue, representing 20.17% of its total revenue.
- Established Pharmaceutical Products generated $5.54 B in revenue, representing 12.49% of its total revenue.
- Medical Devices generated $21.39 B in revenue, representing 48.27% of its total revenue.
- Nutritional Products generated $8.45 B in revenue, representing 19.07% of its total revenue.
The biggest segment for Abbott Laboratories is the Medical Devices, which represents 48.27% of its total revenue.
The smallest segment for Abbott Laboratories is the Established Pharmaceutical Products, which represents 12.49% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Diagnostic Products | 24.91% | 22.28% | 20.17% |
| Established Pharmaceutical Products | 12.63% | 12.39% | 12.49% |
| Medical Devices | 42.12% | 45.28% | 48.27% |
| Nutritional Products | 20.34% | 20.06% | 19.07% |
| Total Revenue | 100% | 100% | 100% |
Abbott Laboratories's Segments Revenue Trend
The above chart shows the revenue trend of different segments of Abbott Laboratories.
In fiscal year 2025, the Medical Devices generated the most revenue ($21.39 B), and the Established Pharmaceutical Products generated the least revenue ($5.54 B).
Abbott Laboratories's Revenue Growth Drivers
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Products & Services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Diagnostic Products | $9.99 B - |
$9.34 B
6.48%
|
$8.94 B
4.33%
|
| Established Pharmaceutical Products | $5.07 B - |
$5.19 B
2.53%
|
$5.54 B
6.58%
|
| Medical Devices | $16.89 B - |
$18.99 B
12.43%
|
$21.39 B
12.65%
|
| Nutritional Products | $8.15 B - |
$8.41 B
3.18%
|
$8.45 B
0.45%
|
| Total Revenue | $40.10 B - |
$41.93 B
4.59%
|
$44.31 B
5.67%
|
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
-
Pfizer Revenue by Segment
